Congrats! An India Patent has been granted
2023-04-17
上午 9:00
(+886) 2-2655-7790
(+886) 2-2655-7730
Rm. ER12A, 17F.-1, No. 3, Park St., Nangang Dist., Taipei City 115, Taiwan (R.O.C.)
GM-XANTHO
Innovator of Botanical New Drugs
Atopic Dermatitis
Atopic dermatitis is an allergic skin disease that is a repeated episode. 50% ~ 80% of patients with atopic dermatitis combined with atopic physique, in addition to skin symptoms, may also be accompanied by elevated IgE, allergic rhinitis or asthma.
Patent
Patents have been granted by US, Taiwan, China and Germany.
Market
Atopic Dermatitis market is in value from $6.4B in 2017 to $18.3B in 2027.
Milestone
Conduct clinical trials Phase I/IIa in 2020.
News
Clinical Phase IIa in Taiwan
2021-05-10
下午 3:00
Clinical Phase I in Taiwan
2021-01-30
上午 9:00
Congrats! IND has authorized by FDA
2019-09-20
上午 9:00